Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, has faced a suspension order for the drug license of one of its stores in Chennai, Tamil Nadu, due to violations under the Drugs and Cosmetics Act. The suspension is set for three days, and it could result in a potential revenue loss of approximately ₹1.50 lakh (1.50 cr). This situation reflects operational challenges for the subsidiary and warrants close monitoring, as regulatory issues like these can impact overall business performance and investor sentiment. Potential risks include reputational damage and operational disruptions that may affect future revenue streams.